CN112190630A - 一种用于视力调节眼膏及其制备方法 - Google Patents
一种用于视力调节眼膏及其制备方法 Download PDFInfo
- Publication number
- CN112190630A CN112190630A CN202011149921.6A CN202011149921A CN112190630A CN 112190630 A CN112190630 A CN 112190630A CN 202011149921 A CN202011149921 A CN 202011149921A CN 112190630 A CN112190630 A CN 112190630A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- kaolin
- glycerol
- polydimethylsiloxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种用于视力调节眼膏及其制备方法,所述用于视力调节眼膏由以下质量份的原料制成:水30~40份、甘油20~30份、鯨蜡硬脂醇2~5份、甘油硬脂酸酯2~5份、高岭土1~2份、决明提取物2~5份、当归根提取物2~6份、薄荷提取物1~8份、枸杞提取物2~8份、丹参根提取物2~6份、红花提取物2~5份、珍珠提取物2~6份、聚二甲基硅氧烷2~8份、蜂蜡2~4份、月桂醇硫酸酯钠2~5份、羟乙基纤维素2~7份、羟苯甲酯2~5份、羟苯丙酯2~8份、双咪唑烷基脲2~8份和香兰基丁基醚2~4份。该用于视力调节眼膏及其制备方法,可辅助视力调节减缓眼部肌肉疲劳,降低视力调节的眼部负担。
Description
技术领域
本发明属于眼膏制备技术领域,具体涉及一种用于视力调节眼膏及其制备方法。
背景技术
现代的眼膏剂包括狭义的眼膏剂、眼用乳膏剂、眼用凝胶剂。眼膏剂系指由药物与适宜基质均匀混合,制成溶液型或混悬型膏状的无菌眼用半固体制剂。眼用乳膏剂是由药物与适宜基质混合均匀,制成的乳膏状的无菌眼用半固体制剂。眼用凝胶剂是由药物与适宜辅料制成的凝胶状无菌眼用半固体制剂。
现有的眼膏剂的功能较为单一,对视力调节后的患者眼部的水分补充能力较为一般。
发明内容
本发明的目的在于提供一种用于视力调节眼膏及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种用于视力调节眼膏,所述用于视力调节眼膏由以下质量份的原料制成:水30~40份、甘油20~30份、鯨蜡硬脂醇2~5份、甘油硬脂酸酯2~5份、高岭土1~2份、决明提取物2~5份、当归根提取物2~6份、薄荷提取物1~8份、枸杞提取物2~8份、丹参根提取物2~6份、红花提取物2~5份、珍珠提取物2~6份、聚二甲基硅氧烷2~8份、蜂蜡2~4份、月桂醇硫酸酯钠2~5份、羟乙基纤维素2~7份、羟苯甲酯2~5份、羟苯丙酯2~8份、双咪唑烷基脲2~8份和香兰基丁基醚2~4份。
优选的,所述用于视力调节眼膏由以下质量份的原料制成:水30份、甘油20份、鯨蜡硬脂醇2份、甘油硬脂酸酯2份、高岭土1份、决明提取物2份、当归根提取物3份、薄荷提取物5份、枸杞提取物4份、丹参根提取物4份、红花提取物3份、珍珠提取物4份、聚二甲基硅氧烷3份、蜂蜡3份、月桂醇硫酸酯钠4份、羟乙基纤维素3份、羟苯甲酯2份、羟苯丙酯2份、双咪唑烷基脲3份和香兰基丁基醚3份。
优选的,所述水经过反渗透、超过滤、微孔膜过滤和电渗析其中任意一种技术进行膜分离纯化处理。
优选的,所述高岭土为粉状粒度为一百二十目。
优选的,所述决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物和珍珠提取物均选择对应的中草药,经过粉碎萃取后得到固体提纯物体。
一种用于视力调节眼膏的制备方法,包括以下步骤:
S1:称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
本发明的技术效果和优点:该用于视力调节眼膏及其制备方法,通过水、甘油、鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷、蜂蜡、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚制备的眼膏补充眼部肌肤水分,改善眼周肌肤细纹,舒缓眼肌肤的干燥和不适,决明、当归、薄荷和丹参等组份起到体谅眼周肤色的作用,恢复眼部肌肤的弹性。
具体实施方式
下面将结合本发明的内容,对本发明中的技术方案进行清楚、完整地描述,显然,所描述的内容仅仅是本发明一部分内容,而不是全部的内容。基于本发明中的内容,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他内容,都属于本发明保护的范围。
实施例1
本发明提供了一种用于视力调节眼膏,所述用于视力调节眼膏由以下质量份的原料制成:水35份、甘油25份、鯨蜡硬脂醇3份、甘油硬脂酸酯2份、高岭土1份、决明提取物4份、当归根提取物2份、薄荷提取物4份、枸杞提取物3份、丹参根提取物3份、红花提取物3份、珍珠提取物4份、聚二甲基硅氧烷3份、蜂蜡3份、月桂醇硫酸酯钠4份、羟乙基纤维素3份、羟苯甲酯2份、羟苯丙酯2份、双咪唑烷基脲3份和香兰基丁基醚3份。
优选的,所述水经过反渗透、超过滤、微孔膜过滤和电渗析其中任意一种技术进行膜分离纯化处理。
优选的,所述高岭土为粉状粒度为一百二十目。
优选的,所述决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物和珍珠提取物均选择对应的中草药,经过粉碎萃取后得到固体提纯物体。
一种用于视力调节眼膏的制备方法,包括以下步骤:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
实施例2
一种用于视力调节眼膏,所述用于视力调节眼膏由以下质量份的原料制成:水40份、甘油30份、鯨蜡硬脂醇4份、甘油硬脂酸酯4份、高岭土2份、决明提取物4份、当归根提取物4份、薄荷提取物5份、枸杞提取物2份、丹参根提取物2份、红花提取物2、珍珠提取物4份、聚二甲基硅氧烷5份、蜂蜡3份、月桂醇硫酸酯钠3份、羟乙基纤维素4份、羟苯甲酯4份、羟苯丙酯3份、双咪唑烷基脲3份和香兰基丁基醚2份。
优选的,所述水经过反渗透、超过滤、微孔膜过滤和电渗析其中任意一种技术进行膜分离纯化处理。
优选的,所述高岭土为粉状粒度为一百二十目。
优选的,所述决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物和珍珠提取物均选择对应的中草药,经过粉碎萃取后得到固体提纯物体。
一种用于视力调节眼膏的制备方法,包括以下步骤:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
实施例3
一种用于视力调节眼膏,所述用于视力调节眼膏由以下质量份的原料制成:水35份、甘油20份、鯨蜡硬脂醇5份、甘油硬脂酸酯5份、高岭土2份、决明提取物5份、当归根提取物4份、薄荷提取物5份、枸杞提取物3份、丹参根提取物4份、红花提取物4份、珍珠提取物6份、聚二甲基硅氧烷5份、蜂蜡2份、月桂醇硫酸酯钠4份、羟乙基纤维素5份、羟苯甲酯3份、羟苯丙酯4份、双咪唑烷基脲3份和香兰基丁基醚3份。
优选的,所述水经过反渗透、超过滤、微孔膜过滤和电渗析其中任意一种技术进行膜分离纯化处理。
优选的,所述高岭土为粉状粒度为一百二十目。
优选的,所述决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物和珍珠提取物均选择对应的中草药,经过粉碎萃取后得到固体提纯物体。
一种用于视力调节眼膏的制备方法,包括以下步骤:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
对比例1
对比例1的配方增加了水与甘油的比例,制备步骤如下:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
对比例2
对比例2中的配方增加了鯨蜡硬脂醇、甘油硬脂酸酯和高岭土、决明提取物、当归根提取物和薄荷提取物的比例,制备步骤如下:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
对比例3
对比例3中的配方增加了水、鯨蜡硬脂醇、高岭土、决明提取物、当归根提取物和红花提取物的比例,降低了枸杞提取物的比例,制备步骤如下:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
具体的,该用于视力调节眼膏中,对实施例1~3与对比例1~3所制备的用于视力调节眼膏进行感官评价和功能性测试,得出实施例1~3与对比例1~3中制备的用于视力调节眼膏,实施例1具有更高的流动性和润肤性,有利于皮肤相对干燥的用户使用,实施例2增加了鯨蜡硬脂醇、甘油硬脂酸酯和高岭土、决明提取物、当归根提取物和薄荷提取物的比例,实施例2具有良好的附着能力以适应油性肌肤使用,实施例3具有最佳的流动性,但附着能力略低,由于决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物的组分特性,起到了补充眼部肌肤水分,改善眼周肌肤细纹,舒缓眼肌肤的干燥和不适,决明、当归、薄荷和丹参等组份起到体谅眼周肤色的作用,恢复眼部肌肤的弹性。
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种用于视力调节眼膏,其特征在于:所述用于视力调节眼膏由以下质量份的原料制成:水30~40份、甘油20~30份、鯨蜡硬脂醇2~5份、甘油硬脂酸酯2~5份、高岭土1~2份、决明提取物2~5份、当归根提取物2~6份、薄荷提取物1~8份、枸杞提取物2~8份、丹参根提取物2~6份、红花提取物2~5份、珍珠提取物2~6份、聚二甲基硅氧烷2~8份、蜂蜡2~4份、月桂醇硫酸酯钠2~5份、羟乙基纤维素2~7份、羟苯甲酯2~5份、羟苯丙酯2~8份、双咪唑烷基脲2~8份和香兰基丁基醚2~4份。
2.根据权利要求1所述的一种用于视力调节眼膏,其特征在于:所述用于视力调节眼膏由以下质量份的原料制成:水30份、甘油20份、鯨蜡硬脂醇2份、甘油硬脂酸酯2份、高岭土1份、决明提取物2份、当归根提取物3份、薄荷提取物5份、枸杞提取物4份、丹参根提取物4份、红花提取物3份、珍珠提取物4份、聚二甲基硅氧烷3份、蜂蜡3份、月桂醇硫酸酯钠4份、羟乙基纤维素3份、羟苯甲酯2份、羟苯丙酯2份、双咪唑烷基脲3份和香兰基丁基醚3份。
3.根据权利要求1~2任一项所述的一种用于视力调节眼膏,其特征在于:所述水经过反渗透、超过滤、微孔膜过滤和电渗析其中任意一种技术进行膜分离纯化处理。
4.根据权利要求1~2任一项所述的一种用于视力调节眼膏,其特征在于:所述高岭土为粉状粒度为一百二十目。
5.根据权利要求1~2任一项所述的一种用于视力调节眼膏,其特征在于:所述决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物和珍珠提取物均选择对应的中草药,经过粉碎萃取后得到固体提纯物体。
6.根据权利要求1~2任一项所述的一种用于视力调节眼膏的制备方法,其特征在于:包括以下步骤:
S1:首先称取上述中各重量份的原料,将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡放置在一起,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚放置在一起,水和甘油单独放置;
S2:将鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡置于搅拌皿内混合,月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚置于另一组搅拌皿内混合;
S3:将甘油分别置于两组蒸煮锅中,其中一组投入鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物加热搅拌,另一组投入月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的混合物加热搅拌;
S4:将甘油、月桂醇硫酸酯钠、羟乙基纤维素、羟苯甲酯、羟苯丙酯、双咪唑烷基脲和香兰基丁基醚构成的加热后的混合物倒入容纳鯨蜡硬脂醇、甘油硬脂酸酯、高岭土、决明提取物、当归根提取物、薄荷提取物、枸杞提取物、丹参根提取物、红花提取物、珍珠提取物、聚二甲基硅氧烷和蜂蜡构成的混合物的蒸煮锅内部;
S5:在蒸煮锅内搅拌的状态下加水稀释混合物获得药膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011149921.6A CN112190630A (zh) | 2020-10-23 | 2020-10-23 | 一种用于视力调节眼膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011149921.6A CN112190630A (zh) | 2020-10-23 | 2020-10-23 | 一种用于视力调节眼膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112190630A true CN112190630A (zh) | 2021-01-08 |
Family
ID=74011046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011149921.6A Pending CN112190630A (zh) | 2020-10-23 | 2020-10-23 | 一种用于视力调节眼膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112190630A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075333A (zh) * | 1992-02-12 | 1993-08-18 | 张秀柱 | 22种新型药酒和保健饮料制作工艺 |
CN104586934A (zh) * | 2013-11-04 | 2015-05-06 | 岑春华 | 一种磁酒石药敷穴位康复带的制作及治疗方法 |
CN108114084A (zh) * | 2018-02-08 | 2018-06-05 | 韩旭东 | 一种用于提高视力的中药组合物及其制备方法 |
CN110559364A (zh) * | 2019-09-06 | 2019-12-13 | 梅河口市益视恒佳视力保健集团有限公司 | 一种新型眼膏的配方 |
-
2020
- 2020-10-23 CN CN202011149921.6A patent/CN112190630A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075333A (zh) * | 1992-02-12 | 1993-08-18 | 张秀柱 | 22种新型药酒和保健饮料制作工艺 |
CN104586934A (zh) * | 2013-11-04 | 2015-05-06 | 岑春华 | 一种磁酒石药敷穴位康复带的制作及治疗方法 |
CN108114084A (zh) * | 2018-02-08 | 2018-06-05 | 韩旭东 | 一种用于提高视力的中药组合物及其制备方法 |
CN110559364A (zh) * | 2019-09-06 | 2019-12-13 | 梅河口市益视恒佳视力保健集团有限公司 | 一种新型眼膏的配方 |
Non-Patent Citations (3)
Title |
---|
刘莉: "增明液外敷合穴位按摩治疗近视眼230例", 《浙江中医杂志》 * |
成都明眸堂健康管理有限责任公司: "善眸护眼膜", 《HTTP://FTBA.NMPA.GOV.CN:8181/ FTBAN/ITOWNET/HZP_BA/ FW/PZ.JSP? PROCESSID =20190121132030RTFCR&NID=20190121132030RTFCR》 * |
王洪峰,等: "中西医结合治疗中小学生假性近视眼1180例临床分析", 《吉林医学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108272707B (zh) | 一种中草药护发素及其制备方法 | |
CN105055289A (zh) | 一种多功能护肤、嫩肤的中药护肤液及其生产方法 | |
CN102266445A (zh) | 一种具有保健和治疗功效的护眼中药组合物 | |
CN110638954A (zh) | 一种美白祛斑组合物及其制备方法 | |
CN1048853C (zh) | 枸杞保健茶 | |
CN101352497A (zh) | 一种祛黄褐斑的中药组合物、其制备方法及其用途 | |
CN106309275A (zh) | 一种皮肤保湿祛痘水及其制备方法 | |
CN102657740A (zh) | 一种白发转黑发的中药组合物及其制备方法 | |
CN104523530A (zh) | 一种抗衰老面膜及其制备方法 | |
CN104887870A (zh) | 一种花青素明目口服液及其制备方法 | |
CN112190630A (zh) | 一种用于视力调节眼膏及其制备方法 | |
CN110960436A (zh) | 护肤组合物、眼霜及其制备方法 | |
CN101024066A (zh) | 金嗓利咽制剂及其制备方法 | |
CN102836108B (zh) | 一种祛斑、痘嫩肤面膜及其生产方法 | |
CN105342966A (zh) | 含有日本医蛭的护肤保湿霜及其制备方法 | |
CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN103340808A (zh) | 一种三七药物晚霜的制备工艺 | |
CN113509411A (zh) | 一种基于山茶籽油的面膜液以及含有该面膜液的面膜 | |
CN103479988A (zh) | 一种天然外用复合防脱生发液的制备方法 | |
CN1121829A (zh) | 产妇催奶健乳口服液及其生产工艺 | |
CN112999306A (zh) | 一种美白祛斑的中药组合物及其应用 | |
CN1090932C (zh) | 一种面部外用软膏及其制备方法 | |
CN113208981A (zh) | 一种草本植物防脱健发膏及其制备方法 | |
CN102210640B (zh) | 一种洗发露及其制备方法 | |
CN111714564A (zh) | 一种治疗脱发的中药组合物、中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210108 |